Congress 2014 has ended
Back To Schedule
Thursday, May 1 • 12:00pm - 1:30pm
New Options, New Hope: Recent Chemotherapeutic Advances in Metastatic Pancreatic Cancer

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Is it possible to impact the survival rates for patients diagnosed with metastatic pancreatic cancer? Please join the Pancreatic Cancer Action Network to learn how you can play a major role in providing encouragement, hope, education, and care to your patients. Presentations will bring to life everyday challenges across the spectrum of this devastating disease, from diagnosis to treatment (including clinical trial referral). They will be delivered by pancreatic care experts, including a physician, nurse, and a representative from a leading pancreatic care organization.

As the national leader in the fight against pancreatic cancer, the Pancreatic Cancer Action Network has a bold goal to double the pancreatic cancer survival rate by 2020. This activity will raise your knowledge and understanding of the most recent progress achieved to date, including incorporating current and newly approved agents into clinical practice. At its close, you’ll hear stories of hope and survival from patients and caregivers striving to move forward in this fight against this devastating disease. Nurses will also be provided with the necessary tools and resources to utilize in your practice. Register here.

Supported by an educational grant from Celgene Corporation. Provided by MediCom Worldwide, Inc. 


Barbara A. Biedrzycki, PhD, CRNP, AOCNP

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Anitra Engebretson

Pancreatic Cancer Action Network

Eileen M. O’Reilly, MD

Memorial Sloan Kettering Cancer Center

Thursday May 1, 2014 12:00pm - 1:30pm PDT
Marquis Ballroom Center Anaheim Marriott Hotel, 700 W. Convention Way, Anaheim, CA 92802
  Industry Event

Attendees (0)